← FDA DRUG APPROVALS

FDA ANDA · ANDA074346

PASER

Sponsor: ADAPTIS

APPLICATION
ANDA074346
TYPE
ANDA
ORIGINAL APPROVAL
1994-06-30
LATEST ACTION
1996-08-27
ROUTE
ORAL
DOSAGE FORM
GRANULE, DELAYED RELEASE
MARKETING STATUS
Prescription

Products

PASERPrescription
AMINOSALICYLIC ACID 4GM/PACKET · GRANULE, DELAYED RELEASE · ORAL

Approval history

1996-08-27Manufacturing (CMC) · Supplement 5AP
1996-08-27Manufacturing (CMC) · Supplement 4AP
1996-08-27Labeling · Supplement 11AP
1996-04-23Manufacturing (CMC) · Supplement 8AP
1996-02-21Manufacturing (CMC) · Supplement 9AP
1995-02-01Manufacturing (CMC) · Supplement 3AP
1995-02-01Manufacturing (CMC) · Supplement 1AP
1995-02-01Manufacturing (CMC) · Supplement 2AP
1994-06-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →